Schonfeld Strategic Advisors LLC Sangamo Therapeutics, Inc Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 31,425 shares of SGMO stock, worth $15,084. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,425
Previous 1,709,615
98.16%
Holding current value
$15,084
Previous $1.74 Million
98.85%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding SGMO
# of Institutions
139Shares Held
52.3MCall Options Held
2.22MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.87MShares$3.3 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.26 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.17MShares$1.52 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.28MShares$1.1 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $75.1M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...